Prostat Spesifik Antijenin Akut Üriner Retansiyon Sonrası Üretral Kateter Yerleştirilen ve Benign Prostat Hiperplazisi Olan Hastalarda Prostat Adenokarsinomu Saptamadaki Rolü-Reference-Cited by-同舟云学术

Prostat Spesifik Antijenin Akut Üriner Retansiyon Sonrası Üretral Kateter Yerleştirilen ve Benign Prostat Hiperplazisi Olan Hastalarda Prostat Adenokarsinomu Saptamadaki Rolü

Published:2020-10-15 Issue: Volume: Page:
ISSN:1305-2489
Container-title:Yeni Üroloji Dergisi
language:
Short-container-title:

Author:

HACIİSLAMOĞLU Ahmet,EVREN İsmail,YAVUZSAN Abdullah Hızır,YİĞİTBAŞI İsmail,EKŞİ Mithat,ŞEKER Kamil Gökhan,TUĞCU Volkan

Publisher

Avrasya Uroonkoloji Dernegi

Reference7 articles.

1. References

2. 1. Bushman W. Etiology, epidemiology, and natural history of benign prostatic hyperplasia. Urol Clin North Am 2009;36:403–15. 2. Bosch JL, Hop WC, Kirkels WJ, Schröder FH. The international prostate symptom score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate, and residual urine volume. Br J Urol. 1995;75(5):622–630. 3. Orsted DD, Bojesen SE, Nielsen SF, Nordestgaard BG. Association of clinical benign prostate hyperplasia with prostate cancer incidence and mortality revisited: a nationwide cohort study of 3,009,258 men. Eur Urol. 2011 Oct;60(4):691-8.4. Alcaraz A, Hammerer P, Tubaro A, Schröder FH, Castro R. Is there evidence of a relationship between benign prostatic hyperplasia and prostate cancer? Findings of a literature review. Eur Urol 2009; 55(4):864–873

3. 5. Schenk JM, Kristal AR, Arnold KB, et al. Association of symptomatic benign prostatic hyperplasia and prostate cancer: results from the prostate cancer prevention trial. Am J Epidemiol 2011, 173(12):1419–1428

4. 6. Simons BD, Morrison AS, Young RH, Verhoek-Oftedahl W. The relation of surgery for prostatic hypertrophy to carcinoma of the prostate. Am J Epidemiol 1999

5. 138(5):294-300 7. Kefi A, Koseoglu H, Celebi I, Yorukoglu K, Esen A. Relation between acute urinary retention, chronic prostatic inflammation, and accompanying elevated prostate-specific antigen. Scand J Urol Nephrol 2006;40:155-60.